TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection
Open Access
- 5 April 2017
- journal article
- research article
- Published by The Royal Society in Royal Society Open Science
- Vol. 4 (4) , 170050
Abstract
Tumour antigens have attracted much attention because of their importance to cancer diagnosis, prognosis and targeted therapy. With the development of cancer genomics, the identification of tumour-specific neoantigens became possible, which is a crucial step for cancer immunotherapy. In this study, we developed software called the tumour-specific neoantigen detector for detecting cancer somatic mutations following the best practices of the genome analysis toolkit and predicting potential tumour-specific neoantigens, which could be either extracellular mutations of membrane proteins or mutated peptides presented by class I major histocompatibility complex molecules. This pipeline was beneficial to the biologist with little programmatic background. We also applied the software to the somatic mutations from the International Cancer Genome Consortium database to predict numerous potential tumour-specific neoantigens. This software is freely available from https://github.com/jiujiezz/tsnad.Keywords
Funding Information
- Natural Science Foundation of Zhejiang Province (LY15C060001)
- National Natural Science Foundation of China (31501021, 81430081)
This publication has 40 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- Mutant proteins as cancer-specific biomarkersProceedings of the National Academy of Sciences, 2011
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- SOAP2: an improved ultrafast tool for short read alignmentBioinformatics, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- The cancer genomeNature, 2009
- NetMHCpan, a method for MHC class I binding prediction beyond humansImmunogenetics, 2008
- A census of human cancer genesNature Reviews Cancer, 2004
- Predicting transmembrane protein topology with a hidden markov model: application to complete genomes11Edited by F. CohenJournal of Molecular Biology, 2001